Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $806859.0.

  • Neuroone Medical Technologies' Other Non-Current Liabilities fell 5391.67% to $806859.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $806859.0, marking a year-over-year decrease of 5391.67%. This contributed to the annual value of $1.3 million for FY2025, which is 4080.81% down from last year.
  • As of Q4 2025, Neuroone Medical Technologies' Other Non-Current Liabilities stood at $806859.0, which was down 5391.67% from $1.3 million recorded in Q3 2025.
  • In the past 5 years, Neuroone Medical Technologies' Other Non-Current Liabilities ranged from a high of $2.1 million in Q3 2024 and a low of $83333.0 during Q1 2021
  • For the 3-year period, Neuroone Medical Technologies' Other Non-Current Liabilities averaged around $1.2 million, with its median value being $1.3 million (2025).
  • Within the past 5 years, the most significant YoY rise in Neuroone Medical Technologies' Other Non-Current Liabilities was 4080.81% (2025), while the steepest drop was 5391.67% (2025).
  • Over the past 3 years, Neuroone Medical Technologies' Other Non-Current Liabilities (Quarter) stood at $83333.0 in 2021, then skyrocketed by 2001.05% to $1.8 million in 2024, then plummeted by 53.92% to $806859.0 in 2025.
  • Its last three reported values are $806859.0 in Q4 2025, $1.3 million for Q3 2025, and $1.0 million during Q2 2025.